Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patients Who Refractory Cancer Conqueror for Bio New Drug Development Translational Research Establishment - Establishment of Personalized Cell Library

NCT01932047 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01932047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01932047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patients Who Refractory Cancer Conqueror for Bio New Drug Development Translational Research Establishment - Establishment of Personalized Cell Library
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2010
Completion date
April 30, 2015
Enrollment
1,523 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory cancer